Related references
Note: Only part of the references are listed.Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation
Thomas Thiele et al.
TRANSFUSION (2011)
Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction
Yanyun Wu et al.
TRANSFUSION (2010)
Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative
D. Smith et al.
VOX SANGUINIS (2010)
High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion
Malte Ziemann et al.
TRANSFUSION (2007)
Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis
EC Vamvakas
TRANSFUSION MEDICINE REVIEWS (2005)
Share Paper
